Patient perceptions concerning clinical trials in oncology patients
| Autor: | Y. Wu, D. Lee, A.L. Dias, J.H. Chao, G.H. Kloecker |
|---|---|
| Rok vydání: | 2016 |
| Předmět: |
medicine.medical_specialty
Randomization Alternative medicine Article law.invention 03 medical and health sciences Clinical trials 0302 clinical medicine Physical medicine and rehabilitation Randomized controlled trial Initial visit law Medicine 030212 general & internal medicine Phase 1 trials Pharmacology lcsh:R5-920 business.industry Investigator initiated trials General Medicine Patient preference Randomized trials Clinical trial Patient perceptions 030220 oncology & carcinogenesis Family medicine Oncology patients lcsh:Medicine (General) business |
| Zdroj: | Contemporary Clinical Trials Communications, Vol 4, Iss C, Pp 179-185 (2016) Contemporary Clinical Trials Communications |
| ISSN: | 2451-8654 |
| DOI: | 10.1016/j.conctc.2016.09.005 |
| Popis: | Background: Clinical trials are critical to scientifically evaluate promising new therapies in oncology, but patient accrual to these studies is persistently low. Patient preference plays an important role in enrollment in these trials. We performed this survey to evaluate the perceptions of newly diagnosed oncology patients about clinical trials and the reasons why they wish to or not to participate in these trials. Methods: Patients were given a ten question survey reflective of their attitudes regarding clinical trials as a treatment option at their initial visit. The self-directed questionnaire was scored on an ordinate scale from strongly agree [1] to strongly disagree [5]. Results: Ninety three patients were surveyed in the cancer specific multispecialty clinics in an academic center. Our patients expected their providers to discuss all information relating to clinical trials and eligibility at the first visit (65.4% agree and 15.4% neutral, p |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|